Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Mantle cell lymphoma physical examination

Introduction

Overview

Overview

Common physical examination findings of Mantle cell lymphoma include fever, rash, splenomegaly, hepatomegaly, peripheral lymphadenopathy, and central lymphadenopathy.

Physical Examination

Physical Examination

Temperature

Skin

Neck

Thorax

Abdomen

Extremities

References

References

  1. ↑ Arati A. Inamdar, Andre Goy, Nehad M. Ayoub, Christen Attia, Lucia Oton, Varun Taruvai, Mark Costales, Yu-Ting Lin, Andrew Pecora & K. Stephen Suh (2016). “Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents”. Oncotarget. 7 (30): 48692–48731. doi:10.18632/oncotarget.8961. PMID 27119356. Unknown parameter |month= ignored (help)
  2. ↑ A. Pawarode, M. R. Baer, S. Padmanabhan, P. K. Wallace, M. Barcos, S. N. J. Sait, A. W. Block, M. Wetzler & M. Battiwalla (2005). “Simultaneous presentation of acute monoblastic leukemia and mantle cell lymphoma: case report and review of the literature”. Leukemia & lymphoma. 46 (12): 1813–1818. doi:10.1080/10428190500244258. PMID 16263586. Unknown parameter |month= ignored (help)
  3. ↑ Julie M. Vose (2017). “Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management”. American journal of hematology. 92 (8): 806–813. doi:10.1002/ajh.24797. PMID 28699667. Unknown parameter |month= ignored (help)
  4. ↑ Julie M. Vose (2017). “Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management”. American journal of hematology. 92 (8): 806–813. doi:10.1002/ajh.24797. PMID 28699667. Unknown parameter |month= ignored (help)
  5. ↑ S. Pittaluga, G. Verhoef, A. Criel, I. Wlodarska, J. Dierlamm, C. Mecucci, H. Van den Berghe & C. De Wolf-Peeters (1996). ““Small” B-cell non-Hodgkin’s lymphomas with splenomegaly at presentation are either mantle cell lymphoma or marginal zone cell lymphoma. A study based on histology, cytology, immunohistochemistry, and cytogenetic analysis”. The American journal of surgical pathology. 20 (2): 211–223. PMID 8554111. Unknown parameter |month= ignored (help)
  6. ↑ Julie M. Vose (2017). “Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management”. American journal of hematology. 92 (8): 806–813. doi:10.1002/ajh.24797. PMID 28699667. Unknown parameter |month= ignored (help)
  7. ↑ Peng Yang, Jun Lin, Hao Liu, Hao Shen & Hui-Lin Yang (2017). “Primary bone mantle cell lymphomas with multiple vertebral compression fractures: A case report”. Oncology letters. 13 (3): 1288–1292. doi:10.3892/ol.2017.5553. PMID 28454248. Unknown parameter |month= ignored (help)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ali Akram, M.B.B.S.[2] Sowminya Arikapudi, M.B,B.S. [3]